GPC3 and hepatocellular carcinoma: Additionally, iron oxide nanoparticles (Fe3O4 NPs) functionalized with glypican-3 ligand peptides (GPC3) were developed for ultrasound imaging and cancer therapy, particularly in hepatocellular carcinoma.